SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950142-19-000251
Filing Date
2019-02-14
Accepted
2019-02-14 08:01:44
Documents
2
Group Members
POINTSTATE CAPITAL LPSTEELMILL MASTER FUND LPZACHARY J. SCHREIBER

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 eh1900179_13ga4-clovis.htm SC 13G/A 136121
2 EXHIBIT 99.1 eh1900179_ex9901.htm EX-99.1 5192
  Complete submission text file 0000950142-19-000251.txt   142951
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Subject) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86488 | Film No.: 19600873
SIC: 2834 Pharmaceutical Preparations

Mailing Address 40 WEST 57TH STREET 25TH FLOOR NEW YORK NY 10019
Business Address 40 WEST 57TH STREET 25TH FLOOR NEW YORK NY 10019 (212) 830-7000
PointState Capital LP (Filed by) CIK: 0001509842 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A